Schedule 13D ownership disclosure

CoLucid Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 19716T101

Event date: 2016-09-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
17.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-709396
Form type
SC 13D/A
Filer
CoLucid Pharmaceuticals, Inc.
CIK
CIK 1348649
Filed
Sep 14, 2016
Reporting period
Sep 09, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub